Cargando…
Impact of Betamethasone Pretreatment on Engrafment of Cord Blood-Derived Hematopoietic Stem Cells
Hematopoietic stem cell (HSC) transplantation is crucial to cure hematologic malignancies. Umbilical cord blood (UCB) is a source of stem cells, but 90% of UCB units are discarded due to low cellularity. Improving the engraftment capacities of CD34(+) stem cells would allow the use of UCB that were...
Autores principales: | Perna-Barrull, David, Gomez-Muñoz, Laia, Rodriguez-Fernandez, Silvia, Gieras, Anna, Ampudia-Carrasco, Rosa M., Almenara-Fuentes, Lidia, Risueño, Ruth M., Querol, Sergi, Tolosa, Eva, Vives-Pi, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760591/ https://www.ncbi.nlm.nih.gov/pubmed/36528821 http://dx.doi.org/10.1007/s00005-022-00666-5 |
Ejemplares similares
-
Immune System Remodelling by Prenatal Betamethasone: Effects on β-Cells and Type 1 Diabetes
por: Perna-Barrull, David, et al.
Publicado: (2020) -
Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes
por: Perna-Barrull, David, et al.
Publicado: (2019) -
Prenatal Administration of Betamethasone Causes Changes in the T Cell Receptor Repertoire Influencing Development of Autoimmunity
por: Gieras, Anna, et al.
Publicado: (2017) -
Prenatal Betamethasone Exposure and its Impact on Pediatric Type 1 Diabetes Mellitus: A Preliminary Study in a Spanish Cohort
por: Perna-Barrull, David, et al.
Publicado: (2022) -
Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes
por: Villalba, Adrian, et al.
Publicado: (2020)